4.4 Review

Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis A systematic review

Related references

Note: Only part of the references are listed.
Article Allergy

The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications

Carina M. Woodruff et al.

Summary: Confirming drug imputability is crucial in managing cutaneous adverse drug reactions (CADR). Patch testing, although widely used, shows significant variability in test positivity among different drugs and types of reactions. It may be worthwhile in certain common CADRs, but its utility is limited and not recommended in complex cases.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)

Review Allergy

Skin tests in the work-up of cutaneous adverse drug reactions: A review and update

Annick Barbaud et al.

Summary: Skin tests, including patch tests, prick tests, and intradermal tests, are valuable in identifying the causes of cutaneous adverse drug reactions and finding safer alternative drugs. Patch tests are useful in studying maculopapular exanthema and severe drug reactions, including acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms. Prick tests are used to evaluate immediate-type hypersensitivity, while intradermal tests can be used for both immediate and delayed-type hypersensitivity reactions.

CONTACT DERMATITIS (2022)

Review Dermatology

Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs

Anton C. de Groot

Summary: This article introduces the diagnostic method of patch testing for delayed cutaneous adverse drug reactions, provides tools and information for performing patch tests safely and properly.

DERMATITIS (2022)

Letter Dermatology

Positive patch testing with omeprazole in Stevens-Johnson syndrome: a case report

E. Van Tendeloo et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Allergy

Evaluation of drug patch tests in children

Sule Buyuk Yaytokgil et al.

Summary: In this study evaluating patch tests with suspect drugs in children, positive results were more common with antiepileptic drugs and in patients with severe cutaneous drug reactions.

ALLERGY AND ASTHMA PROCEEDINGS (2021)

Article Medicine, General & Internal

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The article introduces PRISMA 2020, an updated reporting guideline for systematic reviews and meta-analyses.

PLOS MEDICINE (2021)

Review Immunology

Skin Resident Memory T Cells May Play Critical Role in Delayed-Type Drug Hypersensitivity Reactions

Elisa Maria Schunkert et al.

Summary: Delayed-type drug hypersensitivity reactions (dtDHR) are immune-mediated reactions with a wide range of skin and visceral manifestations. The involvement of T cells, particularly resident memory T cells (T-RM), in the disease pathogenesis is believed to be significant, but remains unclear due to obstacles in defining, identifying, and testing T-RM in dtDHR. Further mechanistic interrogation is necessary to address unanswered questions and implications for prediction, diagnosis, and treatment of the disease.

FRONTIERS IN IMMUNOLOGY (2021)

Article Allergy

A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test

Gil-Soon Choi et al.

Summary: Bortezomib, a drug used in the treatment of multiple myeloma, is associated with common side effects such as gastrointestinal symptoms and peripheral neuropathy, as well as less common cutaneous adverse reactions. Severe cutaneous adverse reactions like Stevens-Johnson syndrome are very rare but can occur. Clinicians should be aware of potential adverse reactions, including SJS, when using bortezomib.

ASIA PACIFIC ALLERGY (2021)

Review Allergy

Drug hypersensitivity in HIV infection

Jonny Peter et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Allergy

Controversies in drug allergy: Testing for delayed reactions

Elizabeth J. Phillips et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Dermatology

Patch testing - a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics

A. Pinho et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Editorial Material Allergy

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Induced by Fexofenadine

S. L. Teo et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2017)

Article Dermatology

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK

Noel Frey et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Review Dermatology

Recent advances in the understanding of severe cutaneous adverse reactions

N. R. Adler et al.

BRITISH JOURNAL OF DERMATOLOGY (2017)

Review Immunology

Adverse cutaneous drug eruptions: current understanding

W. Hoetzenecker et al.

SEMINARS IN IMMUNOPATHOLOGY (2016)

Editorial Material Allergy

Severe reaction to emtricitabine and lamiduvine: evidence of cross-reactivity

Isadora Suarez-Lorenzo et al.

CONTACT DERMATITIS (2016)

Article Dermatology

The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions

Nasreen Hassoun-Kheir et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)

Article Dermatology

Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults

Derek Y. Hsu et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Review Ophthalmology

Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Hajirah N. Saeed et al.

SEMINARS IN OPHTHALMOLOGY (2016)

Review Allergy

Skin Testing and Patch Testing in Non-IgE-Mediated Drug Allergy

Annick Barbaud

CURRENT ALLERGY AND ASTHMA REPORTS (2014)

Article Dermatology

A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions

Y. -T. Lin et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)

Editorial Material Allergy

Stevens-Johnson syndrome and toxic epidermal necrolysis in children

Marina Atanaskovic-Markovic et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)

Article Dermatology

Dithiols as chelators. A cause of bullous skin reactions

J. Storim et al.

HAUTARZT (2011)

Review Genetics & Heredity

Toxic epidermal necrolysis and Stevens-Johnson syndrome

Thomas Harr et al.

ORPHANET JOURNAL OF RARE DISEASES (2010)

Review Pharmacology & Pharmacy

Hypersensitivity to aromatic anticonvulsants: In vivo and in vitro cross-reactivity studies

Antonino Romano et al.

CURRENT PHARMACEUTICAL DESIGN (2006)

Letter Dermatology

Pseudoophedrine-induced toxic epidermal necrolysis

JJ Nagge et al.

ARCHIVES OF DERMATOLOGY (2005)

Article Dermatology

Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption

A Izumi et al.

JOURNAL OF DERMATOLOGY (2005)

Letter Pharmacology & Pharmacy

Antiepileptic drug hypersensitivity syndrome in a patient treated with valproate

JC Arévalo-Lorido et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)

Article Allergy

Tetrazepam drug sensitivity - usefulness of the patch test

C Pirker et al.

CONTACT DERMATITIS (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Toxic epidermal necrolysis after repeated injections of lohexol

A Rosado et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2001)